Pathology, Molecular Biology, and Prognosis of Penile Squamous Cell Carcinoma: What Can We Learn from the Specimen?

被引：0

作者：

Hakenberg, Oliver W. ^{[1
]}

Draeger, Desiree ^{[1
]}

Erbersdobler, Andreas ^{[2
]}

机构：

[1] Univ Med Rostock, Klin & Poliklin Urol, Schillingallee 35, D-18057 Rostock, Germany

[2] Univ Med Rostock, Inst Pathol, Rostock, Germany

来源：

EUROPEAN UROLOGY SUPPLEMENTS | 2018年 / 17卷 / 06期

关键词：

Penile cancer; Squamous cell carcinoma; Prognosis; Molecular carcinogenesis; Biomarkers; Histology; HUMAN-PAPILLOMAVIRUS; P16(INK4A) EXPRESSION; GENE-MUTATIONS; CANCER; METASTASIS; SURVIVAL; LYMPHADENECTOMY; IDENTIFICATION; OPPORTUNITIES; CHEMOTHERAPY;

D O I：

10.1016/j.eursup.2018.05.004

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

In the treatment of penile cancer, there is a need for prognostic and predictive factors allowing assessment of the likelihood of lymph node metastasis, as this would greatly facilitate clinical decision-making for invasive staging of inguinal nodes. Furthermore, systemic chemotherapy in metastatic disease has limited efficacy and more effective additional or second-line therapies are needed. There is a great interest in personalised and targeted therapies at present, but do we have any indications that these will be useful in penile cancer? This review examines the well-proven predictors of prognosis that pathologists can take from specimens, and reports which molecular markers are of proven value in penile cancer. (C) 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved.

引用

页码：138 / 145

页数：8

共 50 条

[21] Proteomics Research to Discover Markers: What Can We Learn from Netflix®?
Ransohoff, David F.
CLINICAL CHEMISTRY, 2010, 56 (02) : 172 - 176
[22] Comparison of Subtypes of Penile Squamous Cell Carcinoma From High and Low Incidence Geographical Regions
Chaux, Alcides
Lezcano, Cecilia
Cubilla, Antonio L.
Tamboli, Pheroze
Ro, Jae
Ayala, Alberto
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2010, 18 (04) : 268 - 277
[23] Insights into the management of penile squamous cell carcinoma: from conventional approaches to emerging novel therapies
Safa, Houssein
Mercinelli, Chiara
Spiess, Philippe E.
Necchi, Andrea
Chahoud, Jad
EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (04) : 447 - 465
[24] Identification of immune related molecular subtypes and prognosis model for predicting prognosis, drug resistance in cervical squamous cell carcinoma
Hu, Dongzhi
Zhang, Zijian
Zhang, Yongjing
Huang, Kangni
Li, Xiaoxue
FRONTIERS IN GENETICS, 2023, 14
[25] Molecular heterogeneity in human stroke - What can we learn from the peripheral blood transcriptome?
Stamova, Boryana
Knepp, Bodie
Rodriguez, Fernando
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2025,
[26] What did we learn from the OPTIMAAL trial? What can we expect from VALIANT?
Dickstein, K
AMERICAN HEART JOURNAL, 2003, 145 (05) : 754 - 757
[27] What can we learn from dietary pattern analysis?
Hodge, Allison
Bassett, Julie
PUBLIC HEALTH NUTRITION, 2016, 19 (02) : 191 - 194
[28] Cutaneous Lymphomas What Can We Learn From Location?
Grange, Florent
Antonicelli, Frank
ARCHIVES OF DERMATOLOGY, 2009, 145 (06) : 710 - 712
[29] What Can We Learn From Elegant Clinical Studies?*
De Maio, Antonio
CRITICAL CARE MEDICINE, 2014, 42 (04) : 972 - 973
[30] Stemming the Hype: What Can We Learn from iPSC Models of Parkinson's Disease and How Can We Learn It?
Jacobs, Benjamin Meir
JOURNAL OF PARKINSONS DISEASE, 2014, 4 (01) : 15 - 27

← 1 2 3 4 5 →